EC
AGN

Eachwin Capital’s Allergan plc AGN Stock Holding History

Eachwin Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$468K Buy
2,033
+509
+33% +$124K 0.43% 78
2016
Q2 		$352K Hold
1,524
– – 0.34% 94
2016
Q1 		$408K Sell
1,524
-32
-2% -$9.16K 0.39% 92
2015
Q4 		$486K Buy
+1,556
New +$463K 0.49% 55

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Eachwin Capital's AGN Position: Q3 2016 in Review

Eachwin Capital increased its Allergan plc (AGN) stake by 33% in Q3 2016, buying an estimated $124K and bringing the position to 2,033 shares worth $468K. The position accounts for 0.43% of the portfolio, ranked #78.

Eachwin Capital first reported a position in AGN in Q4 2015 and has held it in 4 quarters since. The position peaked at $486K in Q4 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Eachwin Capital held 2,033 shares of Allergan plc worth $468K as of Q3 2016.
  • Eachwin Capital bought 509 Allergan plc shares in Q3 2016, an estimated $124K.
  • Allergan plc made up 0.43% of Eachwin Capital's portfolio in Q3 2016, its #78 holding.
  • Eachwin Capital first reported a position in Allergan plc in Q4 2015 and has held it in 4 quarters since.
  • Eachwin Capital's Allergan plc position peaked at $486K in Q4 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Eachwin Capital's 13F filing for Q3 2016, filed 14 Nov 2016.